Philadelphia Pharmaceuticals Dividends and Buybacks
Dividend criteria checks 3/6
Philadelphia Pharmaceuticals is a dividend paying company with a current yield of 4.67% that is well covered by earnings.
Key information
4.7%
Dividend yield
n/a
Buyback Yield
| Total Shareholder Yield | n/a |
| Future Dividend Yield | n/a |
| Dividend Growth | 6.1% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | د.أ0.070 |
| Payout ratio | 63% |
Recent dividend and buyback updates
No updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Whilst dividend payments have been stable, PHIL has been paying a dividend for less than 10 years.
Growing Dividend: PHIL's dividend payments have increased, but the company has only paid a dividend for 6 years.
Dividend Yield vs Market
| Philadelphia Pharmaceuticals Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (PHIL) | 4.7% |
| Market Bottom 25% (JO) | 4.6% |
| Market Top 25% (JO) | 7.7% |
| Industry Average (Pharmaceuticals) | 1.8% |
| Analyst forecast (PHIL) (up to 3 years) | n/a |
Notable Dividend: PHIL's dividend (4.67%) is higher than the bottom 25% of dividend payers in the JO market (4.63%).
High Dividend: PHIL's dividend (4.67%) is low compared to the top 25% of dividend payers in the JO market (7.73%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonable payout ratio (62.7%), PHIL's dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (28.9%), PHIL's dividend payments are well covered by cash flows.